The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. United Therapeutics Corp shares valued at $949,737 were sold by ROTHBLATT MARTINE A on May 07 ’24. At $263.82 per share, ROTHBLATT MARTINE A sold 3,600 shares. The insider’s holdings dropped to 130 shares worth approximately $33941.7 following the completion of this transaction.
Also, ROTHBLATT MARTINE A sold 3,600 shares, netting a total of over 934,929 in proceeds. Following the sale of shares at $259.70 each, the insider now holds 130 shares.
Before that, Olian Judy D. had sold 10,000 shares from its account. In a trade valued at $2,585,601, the Director traded United Therapeutics Corp shares for $258.56 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $1.91 million.
As published in a research note from Goldman on February 12, 2024, United Therapeutics Corp [UTHR] has been rated up from a Sell to a Neutral and the price target has been revised to $215 from $213. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early February. As of December 08, 2023, Wells Fargo has initiated its “an Overweight” rating for UTHR. Earlier on December 06, 2022, UBS initiated its rating. Their recommendation was “a Buy” for UTHR stock.
Analyzing UTHR Stock Performance
During the last five days, there has been a surge of approximately 2.33%. Over the course of the year, United Therapeutics Corp shares have jumped approximately 18.74%. Shares of the company reached a 52-week high of $268.21 on 05/08/24 and a 52-week low of $208.62 on 02/08/24. A 50-day SMA is recorded $239.01, while a 200-day SMA reached $230.33. Nevertheless, trading volume fell to 0.53 million shares from 0.59 million shares the previous day.
Support And Resistance Levels for United Therapeutics Corp (UTHR)
According to the 24-hour chart, there is a support level at 258.43, which, if violated, would cause prices to drop to 255.77. In the upper region, resistance lies at 265.98. The next price resistance is at 270.87. RSI (Relative Strength Index) is 66.07 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 16.23, which suggests the price will increase in the coming days. Percent R is at 20.38%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
